Clinical study "common" name (formal title)	Number of enrollees (per protocol [PP]/intent-to-treat [ITT])	Funding source (pharmaceutical company/National Institutes of Health [NIH])	Year completed	Primary publication	Full study treatment protocol
LAPTOP (Ranibizumab [Lucentis] And Photodynamic Therapy On Polypoidal Choroidal Vasculopathy Study)	97 patients	N/A	N/A	Oishi A, et al. Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results. Am J Ophthalmol. 2013; 156(4):644-651. https://www.ajo.com/article/S0002-9394(13)00361-9/fulltext Oishi A, Miyamoto N, Mandai M, et al. LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy. Ophthalmology. 2014;121(5):1151-1152. https://www.aaojournal.org/article/S0161-6420(13)01258-X/fulltext